TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
GlaxoSmithKline AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
98,742
|
96,709
|
83,395 |
| Financial expenses |
337
|
141
|
38 |
| Earnings before taxes |
2,838
|
3,078
|
2,685 |
| EBITDA |
3,252
|
3,086
|
2,908 |
| Total assets |
38,098
|
30,964
|
31,797 |
| Current assets |
37,356
|
30,323
|
31,683 |
| Current liabilities |
30,023
|
22,499
|
23,241 |
| Equity capital |
8,058
|
8,447
|
8,291 |
| - share capital |
4,353
|
4,506
|
4,493 |
| Employees (average) |
71
|
76
|
70 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
21.2%
|
27.3%
|
26.1% |
| Turnover per employee |
1,391
|
1,272
|
1,191 |
| Profit as a percentage of turnover |
2.9%
|
3.2%
|
3.2% |
| Return on assets (ROA) |
8.3%
|
10.4%
|
8.6% |
| Current ratio |
124.4%
|
134.8%
|
136.3% |
| Return on equity (ROE) |
35.2%
|
36.4%
|
32.4% |
| Change turnover |
5,321
|
13,071
|
4,221 |
| Change turnover % |
6%
|
16%
|
5% |
| Chg. No. of employees |
-5
|
6
|
1 |
| Chg. No. of employees % |
-7%
|
9%
|
1% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.